OPKO Health, Inc. (NYSE:OPK) today announced that senior management will
present at the RBC Capital Markets Global Healthcare Conference in New
York on Tuesday, February 23, 2016 at 3:05 PM (EST).
The presentation will be webcast on the OPKO Investor Relations page of
the corporate website at www.opko.com.
To access the live webcast please log on to the OPKO site approximately
fifteen minutes before the presentation to register and download any
necessary audio software. The audio presentation will be available at
this link for a limited time after the live presentation.
About OPKO Health, Inc.
OPKO Health, Inc. is a diversified healthcare company that seeks to
establish industry-leading positions in large, rapidly growing markets.
Our diagnostics business includes Bio-Reference Laboratories, the
nation's third-largest clinical laboratory with a core genetic testing
business and a 420-person sales force to drive growth and leverage new
products, including the 4Kscore® prostate cancer test and the Claros®1
in-office immunoassay platform. Our pharmaceutical business features
Rayaldee™, a treatment for SHPT in stage 3-4 CKD patients with vitamin D
insufficiency (March 29, 2016 PDUFA date) and VARUBI™ for
chemotherapy-induced nausea and vomiting (oral formulation launched by
partner Tesaro, IV formulation in Phase 3). Our biologics business
includes hGH-CTP, a once-weekly human growth hormone injection (in Phase
3 and partnered with Pfizer), and a long-acting Factor VIIa drug for
hemophilia (entering Phase 2a). We also have production and distribution
assets worldwide, multiple strategic investments and an active business
development strategy. More information is available at www.opko.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160218006074/en/
OPKO Health, Inc.
Tara Mackay, 305-575-4100
Terry Rooney, 212-223-0689
Marie Fields, 212-838-3777
Source: OPKO Health, Inc.
News Provided by Acquire Media